Massi M, Perfumi M, Polidori C, de Caro G
Regul Pept. 1987 Feb;17(2):85-97. doi: 10.1016/0167-0115(87)90015-2.
Intracerebroventricular (i.c.v.) injection of kassinin produced a prompt and copious drinking response at doses of 10-1000 ng/pigeon, in the absence of other behavioural alterations or of changes in core temperature. Neurokinin A and B evoked drinking, but they were respectively 10 and 100 times less potent than kassinin. Intraperitoneal injection of kassinin elicited drinking, but at doses about 1000 X larger than the i.c.v. ones. The angiotensin antagonist [Sar1, Leu8]angiotensin II did not reduce drinking induced by i.c.v. kassinin, suggesting that its effect is not due to interaction with the central renin-angiotensin system. Moreover, the effect is apparently independent of the mechanisms controlling hypovolaemic and hyperosmotic thirst since exact additivity was found in the dipsogenic response when i.c.v. kassinin was administered in the presence of a hypovolaemic (subcutaneous (s.c.), polyethylene glycol) or hyperosmotic (s.c. hypertonic NaCl) dipsogenic stimulus. The present findings show that kassinin, neurokinin A and B share with the tachykinins already tested (eledoisin, physalaemin, substance P) a common dipsogenic action in pigeons. However, marked differences exist in their dipsogenic potency. This order of potency, eledoisin = kassinin = physalaemin greater than neurokinin A = substance P greater than neurokinin B, is not consistent with the tachykinin receptor subtypes so far proposed.
向脑室注射蛙皮素,剂量为10 - 1000纳克/只鸽子时,能迅速引起大量饮水反应,且无其他行为改变或核心体温变化。神经激肽A和B也能引起饮水,但效力分别比蛙皮素低10倍和100倍。腹腔注射蛙皮素也能引起饮水,但所需剂量比脑室注射时大1000倍左右。血管紧张素拮抗剂[Sar1, Leu8]血管紧张素II不能减少脑室注射蛙皮素引起的饮水,这表明其作用并非通过与中枢肾素 - 血管紧张素系统相互作用介导。此外,该作用显然独立于控制低血容量性和高渗性口渴的机制,因为当在低血容量性(皮下注射聚乙二醇)或高渗性(皮下注射高渗氯化钠)致渴刺激存在的情况下脑室注射蛙皮素时,在饮水反应中发现了精确的相加效应。目前的研究结果表明,蛙皮素、神经激肽A和B与已测试的速激肽(依地多辛、雨蛙肽、P物质)在鸽子中具有共同的致渴作用。然而,它们的致渴效力存在显著差异。这种效力顺序为依地多辛 = 蛙皮素 = 雨蛙肽大于神经激肽A = P物质大于神经激肽B,与目前提出的速激肽受体亚型不一致。